Track topics on Twitter Track topics that are important to you
EluSys Therapeutics, Inc. is focused on the development and commercialization of the EluSys Heteropolymer System (the "Technology" or "HP System"), a novel platform technology to treat a wide variety of blood-borne infections and autoimmune diseases. The HP System should enable the rapid, safe and efficient removal and destruction of viral particles, bacteria, toxins and autoantibodies from the bloodstream by injecting a therapeutic compound into the patient. The HP System may be tailored to remove and destroy members of the major classes of blood-borne pathogen within several hours of administration, thus potentially providing an effective treatment for a broad array of different diseases.
10 Bloomfield AvenueP.O. Box 102
United States of America
PINE BROOK, N.J., Sept. 8, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing biodefense countermeasures, announced today that it has been awarded th...
MENLO PARK, CA -- (Marketwired) -- 05/04/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre...
WASHINGTON, July 1, 2013 /PRNewswire/ -- The Alliance for Biosecurity announced it recently elected Anders Hedegaard, President and CEO, Bavarian Nordic, and Elizabeth Posillico, PhD, President and CE...
Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.
ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...
Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...
Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...
CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...
ALDEX GS™ Tablets
ALDEX GS DMTablets
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
Elusys Therapeutics, a private company based in Pine Brook, New Jersey, is focused on the development of antibody therapeutics for the treatment of life-threatening disease. Current investors include ...
Elusys Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using proprietary Heteropolymer (HP) Antibodies for the treat...
EluSys Therapeutics, Inc. is focused on the development and commercialization of the EluSys Heteropolymer System (the "Technology" or "HP System"), a novel platform technology to treat a wide variety...
The Alliance for Biosecurity was formed in June of 2005 by biopharmaceutical companies and the Center for Biosecurity of the University of Pittsburgh Medical Center. Alliance members are committed to...
We have published hundreds of EluSys Therapeutics Incorporated news stories on BioPortfolio along with dozens of EluSys Therapeutics Incorporated Clinical Trials and PubMed Articles about EluSys Therapeutics Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EluSys Therapeutics Incorporated Companies in our database. You can also find out about relevant EluSys Therapeutics Incorporated Drugs and Medications on this site too.
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...